Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Endocrine
Published in: Endocrine 3/2014

01-12-2014 | Review

New vistas in the diagnosis of diabetic polyneuropathy

Authors: Nikolaos Papanas, Dan Ziegler

Published in: Endocrine | Issue 3/2014

Login to get access

Abstract

New modalities are now available to improve the diagnosis of diabetic polyneuropathy (DPN). The present review discusses the progress achieved in this area. First, the minimal diagnostic criteria have been better clarified. Moreover, there are now new bedside tests available, such as the indicator test Neuropad, NeuroQuick, Ipswich Touch Test (IpTT), Vibratip, NC-stat®/DPNCheck™ for automated nerve conduction study (NCS), tactile circumferential discriminator, steel ball-bearing, and SUDOSCAN®, while more sophisticated modalities include skin biopsy and corneal confocal microscopy (CCM). Some tests can be used as screening tools, including primary care setting (Neuropad, IpTT, Vibratip, automated NCS), while others are more suitable for research, including evaluation of DPN in prospective studies (CCM, skin biopsy). Importantly, there is some evidence of earlier DPN diagnosis with the aid of some tests (Neuropad, skin biopsy, CCM). Further advantages provided by different tests are educational value and self-examination. Thus far, the potential of these tests has not been fully utilised. In particular, they have not been validated against standardised clinical examination scores in terms of predicting foot ulcers and amputations. Hence, it now remains to investigate the potential benefits from the widespread use of these tests for earlier and easier diagnosis of DPN in the everyday clinic.
Literature
1.
A.J. Boulton, A.I. Vinik, J.C. Arezzo, V. Bril, E.L. Feldman, R. Freeman, R.A. Malik, R.E. Maser, J.M. Sosenko, D. Ziegler, American Diabetes Association. Diabetic neuropathies: a statement by the American Diabetes Association. Diabetes Care 28, 956–962 (2005)PubMedCrossRef
2.
S. Tesfaye, A.J. Boulton, P.J. Dyck, R. Freeman, M. Horowitz, P. Kempler, G. Lauria, R.A. Malik, V. Spallone, A. Vinik, L. Bernardi, P. Valensi, Toronto Diabetic Neuropathy Expert Group. Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care 33, 2285–2293 (2010)PubMedCentralPubMedCrossRef
3.
A.L. Carrington, J.E. Shaw, C.H. Van Schie, C.A. Abbott, L. Vileikyte, A.J. Boulton, Can motor nerve conduction velocity predict foot problems in diabetic subjects over a 6-year outcome period? Diabetes Care 25, 2010–2015 (2002)PubMedCrossRef
4.
N. Papanas, E. Maltezos, The diabetic foot: established and emerging treatments. Acta Clin. Belg. 62, 230–238 (2007)PubMedCrossRef
5.
A.J. Boulton, The diabetic foot: grand overview, epidemiology and pathogenesis. Diabetes Metab. Res. Rev. 24(Suppl 1), S3–S6 (2008)PubMedCrossRef
6.
N. Papanas, E. Maltezos, M. Edmonds, Salvation of the diabetic foot: still a quest for the Holy Grail? Vasa 40, 267–269 (2011)PubMedCrossRef
7.
A.J. Boulton, R.S. Kirsner, L. Vileikyte, Clinical practice. Neuropathic diabetic foot ulcers. N. Engl. J. Med. 351, 48–55 (2004)PubMedCrossRef
8.
9.
N.K. Chammas, R.L. Hill, A.V. Foster, M.E. Edmonds, Is neuropathic ulceration the key to understanding increased mortality due to ischaemic heart disease in diabetic foot ulcer patients? A population approach using a proportionate model. J. Int. Med. Res. 30, 553–559 (2002)PubMedCrossRef
10.
J. van Baal, R. Hubbard, F. Game, W. Jeffcoate, Mortality associated with acute Charcot foot and neuropathic foot ulceration. Diabetes Care 33, 1086–1089 (2010)PubMedCentralPubMedCrossRef
11.
N. Papanas, A.I. Vinik, D. Ziegler, Neuropathy in prediabetes: does the clock start ticking early? Nat. Rev. Endocrinol. 7, 682–690 (2011)PubMedCrossRef
12.
N. Papanas, D. Ziegler, Polyneuropathy in impaired glucose tolerance: is postprandial hyperglycemia the main culprit? A mini-review. Gerontology 59, 193–198 (2013)PubMedCrossRef
13.
N. Papanas, D. Ziegler, New diagnostic tests for diabetic distal symmetric polyneuropathy. J. Diabetes Complic. 25, 44–51 (2011)CrossRef
14.
N. Papanas, A.J. Boulton, R.A. Malik, C. Manes, O. Schnell, V. Spallone, N. Tentolouris, S. Tesfaye, P. Valensi, D. Ziegler, P. Kempler, A simple new non-invasive sweat indicator test for the diagnosis of diabetic neuropathy. Diabet. Med. 30, 525–534 (2013)PubMedCrossRef
15.
D. Ziegler, E. Siekierka-Kleiser, B. Meyer, M. Schweers, Validation of a novel screening device (NeuroQuick) for quantitative assessment of small nerve fiber dysfunction as an early feature of diabetic polyneuropathy. Diabetes Care 28, 1169–1174 (2005)PubMedCrossRef
16.
G. Rayman, P.R. Vas, N. Baker, C.G. Taylor Jr, C. Gooday, A.I. Alder, M. Donohoe, The Ipswich Touch Test: a simple and novel method to identify inpatients with diabetes at risk of foot ulceration. Diabetes Care 34, 1517–1518 (2011)PubMedCentralPubMedCrossRef
17.
F.L. Bowling, C.A. Abbott, W.E. Harris, S. Atanasov, R.A. Malik, A.J. Boulton, A pocket-sized disposable device for testing the integrity of sensation in the outpatient setting. Diabet. Med. 29, 1550–1552 (2012)PubMedCrossRef
18.
N. Bracewell, F. Game, W. Jeffcoate, B.E. Scammell, Clinical evaluation of a new device in the assessment of peripheral sensory neuropathy in diabetes. Diabet. Med. 29, 1553–1555 (2012)PubMedCrossRef
19.
A.I. Vinik, X. Kong, J.T. Megerian, S.N. Gozani, Diabetic nerve conduction abnormalities in the primary care setting. Diabetes Technol. Ther. 8, 654–662 (2006)PubMedCrossRef
20.
L. Vileikyte, G. Hutchings, S. Hollis, A.J. Boulton, The tactile circumferential discriminator. A new, simple screening device to identify diabetic patients at risk of foot ulceration. Diabetes Care 20, 623–626 (1997)PubMedCrossRef
21.
N. Papanas, A. Gries, E. Maltezos, R. Zick, The steel ball-bearing test: a new test for evaluating protective sensation in the diabetic foot. Diabetologia 49, 739–743 (2006)PubMedCrossRef
22.
J.H. Calvet, J. Dupin, H. Winiecki, P.E. Schwarz, Assessment of small fiber neuropathy through a quick, simple and non invasive method in a German diabetes outpatient clinic. Exp. Clin. Endocrinol. Diabetes 121, 80–83 (2013)PubMed
23.
G. Lauria, M. Bakkers, C. Schmitz, R. Lombardi, P. Penza, G. Devigili, A.G. Smith, S.T. Hsieh, S.I. Mellgren, T. Umapathi, D. Ziegler, C.G. Faber, I.S. Merkies, Intraepidermal nerve fiber density at the distal leg: a worldwide normative reference study. J. Peripher. Nerv. Syst. 15, 202–207 (2010)PubMedCrossRef
24.
N. Papanas, D. Ziegler, Corneal confocal microscopy: a new technique for early detection of diabetic neuropathy. Curr. Diab. Rep. 13, 488–499 (2013)PubMedCrossRef
25.
N. Papanas, K. Papatheodorou, D. Christakidis, D. Papazoglou, G. Giassakis, H. Piperidou, C. Monastiriotis, E. Maltezos, Evaluation of a new indicator test for sudomotor function (Neuropad®) in the diagnosis of peripheral neuropathy in type 2 diabetic patients. Exp. Clin. Endocrinol. Diabetes 113, 195–198 (2005)PubMedCrossRef
26.
N. Papanas, K. Papatheodorou, D. Papazoglou, D. Christakidis, C. Monastiriotis, E. Maltezos, The new indicator test (Neuropad): a valuable diagnostic tool for small-fiber impairment in patients with type 2 diabetes. Diabetes Educ. 33, 257–266 (2007)PubMedCrossRef
27.
V. Spallone, R. Morganti, M. Siampli, T. Fedele, C. D’Amato, L. Cacciotti, M.R. Maiello, Neuropad as a diagnostic tool for diabetic autonomic and sensorimotor neuropathy. Diabet. Med. 26, 686–692 (2009)PubMedCrossRef
28.
N. Papanas, P. Paschos, D. Papazoglou, K. Papatheodorou, K. Paletas, E. Maltezos, A. Tsapas, Accuracy of the Neuropad test for the diagnosis of distal symmetric polyneuropathy in type 2 diabetes. Diabetes Care 34, 1378–1382 (2011)PubMedCentralPubMedCrossRef
29.
N. Papanas, G. Giassakis, K. Papatheodorou, D. Papazoglou, C. Monastiriotis, D. Christakidis, H. Piperidou, E. Maltezos, Use of the new indicator test (Neuropad) for the assessment of the staged severity of neuropathy in type 2 diabetic patients. Exp. Clin. Endocrinol. Diabetes 115, 58–61 (2007)PubMedCrossRef
30.
D. Ziegler, N. Papanas, M. Roden, for the GDC Study Group, Neuropad: evaluation of three cut-off points of sudomotor dysfunction for early detection of polyneuropathy in recently diagnosed diabetes. Diabet. Med. 28, 1412–1415 (2011)PubMedCrossRef
31.
C. Manes, N. Papanas, T. Exiara, N. Katsiki, S. Papantoniou, E. Kirlaki, S. Tsotoulidis, N. Kefalogiannis, E. Maltezos, The indicator test Neuropad in the assessment of small and overall nerve fibre dysfunction in patients with type 2 diabetes: a large multicentre study. Exp. Clin. Endocrinol. Diabetes 122, 195–199 (2014)PubMedCrossRef
32.
A. Tsapas, A. Liakos, P. Paschos, T. Karagiannis, E. Bekiari, N. Tentolouris, P. Boura, A simple plaster for screening for diabetic neuropathy: a diagnostic test accuracy systematic review and meta-analysis. Metabolism 63, 584–592 (2014)PubMedCrossRef
33.
N. Tentolouris, V. Achtsidis, K. Marinou, N. Katsilambros, Evaluation of the self-administered indicator plaster Neuropad for the diagnosis of neuropathy in diabetes. Diabetes Care 31, 236–237 (2008)PubMedCrossRef
34.
N. Papanas, K. Papatheodorou, D. Papazoglou, S. Kotsiou, E. Maltezos, A prospective study on the use of the indicator test Neuropad for the early diagnosis of peripheral neuropathy in type 2 diabetes. Exp. Clin. Endocrinol. Diabetes 119, 122–125 (2011)PubMedCrossRef
35.
N. Papanas, K. Papatheodorou, D. Papazoglou, D. Christakidis, C. Monastiriotis, E. Maltezos, Reproducibility of the new indicator test for sudomotor function (Neuropad) in patients with type 2 diabetes mellitus: short communication. Exp. Clin. Endocrinol. Diabetes 113, 577–581 (2005)PubMedCrossRef
36.
D. Ziegler, N. Papanas, W. Rathmann, M. Heier, M. Scheer, C. Meisinger, KORA Study Group. Evaluation of the Neuropad sudomotor function test as a screening tool for polyneuropathy in the elderly population with diabetes and pre-diabetes: the KORA F4 survey. Diabetes Metab. Res. Rev. 28, 692–697 (2012)PubMedCrossRef
37.
M.J. Young, A.J. Boulton, A.F. MacLeod, D.R. Williams, P.H. Sonksen, A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population. Diabetologia 36, 150–154 (1993)PubMedCrossRef
38.
B.A. Perkins, J. Grewal, E. Ng, M. Ngo, V. Bril, Validation of a novel point-of-care nerve conduction device for the detection of diabetic sensorimotor polyneuropathy. Diabetes Care 29, 2023–2027 (2006)PubMedCrossRef
39.
A.I. Vinik, M.S. Emley, J.T. Megerian, S.N. Gozani, Median and ulnar nerve conduction measurements in patients with symptoms of diabetic peripheral neuropathy using the NC-stat system. Diabetes Technol. Ther. 6, 816–824 (2004)PubMedCrossRef
40.
X. Kong, S.N. Gozani, M.T. Hayes, D.H. Weinberg, NC-stat sensory nerve conduction studies in the median and ulnar nerves of symptomatic patients. Clin. Neurophysiol. 117, 405–413 (2006)PubMedCrossRef
41.
X. Kong, E.A. Lesser, J.T. Megerian, S.N. Gozani, Repeatability of nerve conduction measurements using automation. J. Clin. Monit. Comput. 20, 405–410 (2006)PubMedCentralPubMedCrossRef
42.
B. Boettcher, B. Tracey, X. Kong, M. Williams, S.N. Gozani, A rapid, low-cost, point-of-care test for diabetic peripheral neuropathy. Diabetes 60, 637 (2011)
43.
X. Kong, B. Boettcher, K. Snow, S. Gozani, Reproducibility of a rapid point-of-care sural nerve conduction test. Diabetes 61, 595 (2012)
44.
A.I. Vinik, S.N. Gozani, Loss of sural responses estimated by a rapid and easily administered technique identifies greater neuropathy severity and risk in a general diabetes population. Diabetes 60, 650 (2011)
45.
J.A. Lee, E.M. Halpern, L.E. Lovblom, E. Yeung, V. Bril, B.A. Perkins, Reliability and validity of a point-of-care sural nerve conduction device for identification of diabetic neuropathy. PLoS ONE 9, e86515 (2014)PubMedCentralPubMedCrossRef
46.
R.E. Maser, C. Laudadio, M.J. Lenhard, G.S. DeCherney, A cross-sectional study comparing two quantitative sensory testing devices in individuals with diabetes. Diabetes Care 20, 179–181 (1997)PubMedCrossRef
47.
H. Gin, R. Baudoin, C.H. Raffaitin, V. Rigalleau, C. Gonzalez, Non-invasive and quantitative assessment of sudomotor function for peripheral diabetic neuropathy evaluation. Diabetes Metab. 37, 527–532 (2011)PubMedCrossRef
48.
C.M. Casellini, H.K. Parson, M.S. Richardson, M.L. Nevoret, A.I. Vinik, Sudoscan, a noninvasive tool for detecting diabetic small fiber neuropathy and autonomic dysfunction. Diabetes Technol. Ther. 15, 948–953 (2013)PubMedCentralPubMedCrossRef
49.
S. Løseth, E. Stålberg, R. Jorde, S.I. Mellgren, Early diabetic neuropathy: thermal thresholds and intraepidermal nerve fibre density in patients with normal nerve conduction studies. J. Neurol. 255, 1197–1202 (2008)PubMedCrossRef
50.
Joint Task Force of the EFNS and the PNS, European Federation of Neurological Societies/Peripheral Nerve Society Guideline on the use of skin biopsy in the diagnosis of small fiber neuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society. J. Peripher. Nerv. Syst. 15, 79–92 (2010)CrossRef
51.
52.
C. Quattrini, M. Jeziorska, A.J. Boulton, R.A. Malik, Reduced vascular endothelial growth factor expression and intra-epidermal nerve fiber loss in human diabetic neuropathy. Diabetes Care 31, 140–145 (2008)PubMedCrossRef
53.
C. Quattrini, M. Tavakoli, M. Jeziorska, P. Kallinikos, S. Tesfaye, J. Finnigan, A. Marshall, A.J. Boulton, N. Efron, R.A. Malik, Surrogate markers of small fiber damage in human diabetic neuropathy. Diabetes 56, 2148–2154 (2007)PubMedCrossRef
54.
H. Narayanaswamy, P. Facer, V.P. Misra, M. Timmers, G. Byttebier, T. Meert, P. Anand, A longitudinal study of sensory biomarkers of progression in patients with diabetic peripheral neuropathy using skin biopsies. J. Clin. Neurosci. 19, 1490–1496 (2012)PubMedCrossRef
55.
M. Polydefkis, P. Hauer, S. Sheth, M. Sirdofsky, J.W. Griffin, J.C. McArthur, The time course of epidermal nerve fibre regeneration: studies in normal controls and in people with diabetes, with and without neuropathy. Brain 127, 1606–1615 (2004)PubMedCrossRef
56.
D. Ziegler, N. Papanas, A. Zhivov, S. Allgeier, K. Winter, I. Ziegler, J. Brüggemann, A. Strom, S. Peschel, B. Köhler, O. Stachs, R. F. Guthoff, M. Roden, for the GDS Group, Early detection of nerve fiber loss by corneal confocal microscopy and skin biopsy in recently diagnosed type 2 diabetes. Diabetes. doi:10.​2337/​db13-1819
57.
A. Strom, J. Brüggemann, I. Ziegler, K. Jeruschke, J. Weiss, H. Al-Hasani, M. Roden, D. Ziegler, for the GDS Group, Pronounced reduction of cutaneous Langerhans cell density in recently diagnosed type 2 diabetes. Diabetes 63, 1148–1153 (2014)PubMedCrossRef
58.
B. Köhler, S. Allgeier, F. Eberle, R. Guthoff, S. Maier, O. Stachs, A. Zhivov, D. Ziegler, G. Bretthauer, Image reconstruction of the corneal subbasal nerve plexus with extended field of view from focus image stacks of a confocal laser scanning microscope. Klin. Monbl. Augenheilkd. 228, 1060–1066 (2011)PubMedCrossRef
59.
E.A. Sellers, I. Clark, M. Tavakoli, H.J. Dean, J. McGavock, R.A. Malik, The acceptability and feasibility of corneal confocal microscopy to detect early diabetic neuropathy in children: a pilot study. Diabet. Med. 30, 630–631 (2013)PubMedCrossRef
60.
C. Quattrini, M. Tavakoli, P. Kallinikos et al., Comparing skin biopsy with corneal confocal microscopy: diagnostic yield of nerve fiber density. Diabetologia 53(Suppl 1), A1114 (2010)
61.
M. Tavakoli, C. Quattrini, P. Begum et al., Neuropad and corneal confocal microscopy: new indications for human diabetic neuropathy. Diabetologia 53(Suppl 1), A1112 (2010)
62.
F. Ishibashi, R. Kojima, A. Kawasaki, E. Yamanaka, A. Kosaka, H. Uetake, Correlation between sudomotor function, sweat gland duct size and corneal nerve fiber pathology in patients with type 2 diabetes mellitus. J. Diabetes Invest. (2013). doi:10.​1111/​jdi.​12171
63.
M. Tavakoli, P. Kallinikos, A. Iqbal, A. Herbert, H. Fadavi, N. Efron, A.J. Boulton, R.A. Malik, Corneal confocal microscopy detects improvement in corneal nerve morphology with an improvement in risk factors for diabetic neuropathy. Diabet. Med. 28, 1261–1267 (2011)PubMedCentralPubMedCrossRef
64.
M. Tavakoli, M. Mitu-Pretorian, I.N. Petropoulos, H. Fadavi, O. Asghar, U. Alam, G. Ponirakis, M. Jeziorska, A. Marshall, N. Efron, A.J. Boulton, T. Augustine, R.A. Malik, Corneal confocal microscopy detects early nerve regeneration in diabetic neuropathy after simultaneous pancreas and kidney transplantation. Diabetes 62, 254–260 (2013)PubMedCentralPubMedCrossRef
65.
N. Efron, K. Edwards, N. Roper, N. Pritchard, G.P. Sampson, A.M. Shahidi, D. Vagenas, A. Russell, J. Graham, M.A. Dabbah, R.A. Malik, Repeatability of measuring corneal subbasal nerve fiber length in individuals with type 2 diabetes. Eye Contact Lens 36, 245–248 (2010)PubMedCrossRef
66.
P. Hertz, V. Bril, A. Orszag, A. Ahmed, E. Ng, P. Nwe, M. Ngo, P.A. Perkins, Reproducibility of in vivo corneal confocal microscopy as a novel screening test for early diabetic sensorimotor polyneuropathy. Diabet. Med. 28, 1253–1260 (2011)PubMedCrossRef
67.
I.N. Petropoulos, T. Manzoor, P. Morgan, H. Fadavi, O. Asghar, U. Alam, G. Ponirakis, M.A. Dabbah, X. Chen, J. Graham, M. Tavakoli, R.A. Malik, Repeatability of in vivo corneal confocal microscopy to quantify corneal nerve morphology. Cornea 32, e83–e89 (2013)PubMedCrossRef
68.
W.H. Herman, L. Kennedy, Underdiagnosis of peripheral neuropathy in type 2 diabetes. Diabetes Care 28, 1480–1841 (2005)PubMedCrossRef
69.
C. Gazzaruso, A. Coppola, T. Montalcini, E. Baffero, A. Garzaniti, G. Pelissero, S. Collaviti, A. Grugnetti, P. Gallotti, A. Pujia, S.B. Solerte, A. Giustina, Lipoprotein(a) and homocysteine as genetic risk factors for vascular and neuropathic diabetic foot in type 2 diabetes mellitus. Endocrine 41, 89–95 (2012)PubMedCrossRef
70.
71.
R. Sayın, M. Aslan, M. E. Kucukoglu, A. Luleci, M. Atmaca, R. Esen, H. Demir, Serum prolidase enzyme activity and oxidative stress levels in patients with diabetic neuropathy. Endocrine. doi:10.​1007/​s12020-013-0136-3
Metadata
Title
New vistas in the diagnosis of diabetic polyneuropathy
Authors
Nikolaos Papanas
Dan Ziegler
Publication date
01-12-2014
Publisher
Springer US
Published in
Endocrine / Issue 3/2014
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-014-0285-z

Other articles of this Issue 3/2014

Endocrine 3/2014 Go to the issue

Mini Review

Ectopic ACTH-secreting pituitary adenomas within the sphenoid sinus

Original Article

Carotid intima-media thickness is not associated with vitamin D and PTH levels in patients admitted to an Internal Medicine Department

Original Article

Cushing’s syndrome in type 2 diabetes patients with poor glycemic control

Original Article

Comparative analysis of glucoinsulinemic markers and proinflammatory cytokines in prepubertal children born large-versus appropriate-for gestational age

Original Article

Cardiorespiratory fitness in older adult women: relationships with serum 25-hydroxyvitamin D

Meta-Analysis

Meta-analysis of the association of ADIPOQ G276T polymorphism with insulin resistance and blood glucose
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits